Cathie Wood的ARK ETF公布了2024年10月17日星期四的每日交易情况，重点关注生物科技板块。当天最显著的投资是对CRISPR Therapeutics AG (NASDAQ:CRSP)的购买，ARK通过其ARKK和ARKG ETF共购入91,665股，总价值达4,491,585美元。这次购买延续了ARK一直以来增持这家基因编辑公司的趋势，表明ARK对CRISPR的潜力有强烈的信心 ...

A word of warning for traders who’ve been pouring billions into Chinese-stock ETFs like never before: The strategy is not ...

An updated version of Exact Sciences' key product just got regulatory approval. That could help the healthcare stock stage a ...

Cathie Wood的ARK ETF公布了2024年10月15日星期二的每日交易情况，展示了在科技和医疗保健板块的一系列精心计算的操作。当天活动的主角是对TEMPUS AI INC (NASDAQ:TEM)的大额投资，ARK通过其ARKK和ARKG ...

Recently, I was taking a look at some 13F filings and discovered that another well-known Wall Street titan, Israel Englander of Millennium Management, purchased 30.9 million shares of Nu Holdings last ...

It could be that despite how promising Recursion looks, Cathie Wood and her team think there are even better plays out there. Or, more likely, Recursion's project still looks speculative ...

How about getting some inspiration from famous investors? Cathie Wood, the CEO of Ark Invest, has several AI stocks in her investment management firm's actively managed ETFs. One of them is ...

Cathie Wood, the CEO of ARK Invest, is well known for her bold inventions in popular, innovative tech through the company’s various funds, including her flagship fund, ARK Innovation ETF (NYSE ...

Ark Invest CEO Cathie Wood is one of the most outspoken personalities on Wall Street. Wood has garnered a large following thanks to her consistently bullish convictions around emerging technologies.